vs

Side-by-side financial comparison of ICON PLC (ICLR) and Invesco (IVZ). Click either name above to swap in a different company.

ICON PLC is the larger business by last-quarter revenue ($2.0B vs $1.7B, roughly 1.2× Invesco). ICON PLC runs the higher net margin — 0.1% vs -58.9%, a 59.0% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs 0.6%). Invesco produced more free cash flow last quarter ($432.2M vs $333.9M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 0.6%).

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation. As of February 2025 had approximately 41,900 employees in 55 countries.

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

ICLR vs IVZ — Head-to-Head

Bigger by revenue
ICLR
ICLR
1.2× larger
ICLR
$2.0B
$1.7B
IVZ
Growing faster (revenue YoY)
IVZ
IVZ
+5.6% gap
IVZ
6.2%
0.6%
ICLR
Higher net margin
ICLR
ICLR
59.0% more per $
ICLR
0.1%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$98.3M more FCF
IVZ
$432.2M
$333.9M
ICLR
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
0.6%
ICLR

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ICLR
ICLR
IVZ
IVZ
Revenue
$2.0B
$1.7B
Net Profit
$2.4M
$-995.9M
Gross Margin
Operating Margin
4.2%
-86.2%
Net Margin
0.1%
-58.9%
Revenue YoY
0.6%
6.2%
Net Profit YoY
-98.8%
-575.8%
EPS (diluted)
$0.03
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICLR
ICLR
IVZ
IVZ
Q4 25
$1.7B
Q3 25
$2.0B
$1.6B
Q2 25
$2.0B
$1.5B
Q1 25
$2.0B
$1.5B
Q4 24
$1.6B
Q3 24
$2.0B
$1.5B
Q2 24
$2.1B
$1.5B
Q1 24
$2.1B
$1.5B
Net Profit
ICLR
ICLR
IVZ
IVZ
Q4 25
$-995.9M
Q3 25
$2.4M
$356.4M
Q2 25
$183.0M
$197.4M
Q1 25
$154.2M
$171.1M
Q4 24
$209.3M
Q3 24
$197.1M
$55.0M
Q2 24
$146.9M
$132.2M
Q1 24
$187.4M
$141.5M
Operating Margin
ICLR
ICLR
IVZ
IVZ
Q4 25
-86.2%
Q3 25
4.2%
16.5%
Q2 25
10.4%
14.1%
Q1 25
11.0%
18.1%
Q4 24
19.6%
Q3 24
14.1%
6.6%
Q2 24
10.8%
13.9%
Q1 24
13.7%
14.4%
Net Margin
ICLR
ICLR
IVZ
IVZ
Q4 25
-58.9%
Q3 25
0.1%
21.7%
Q2 25
9.1%
13.0%
Q1 25
7.7%
11.2%
Q4 24
13.1%
Q3 24
9.7%
3.6%
Q2 24
6.9%
8.9%
Q1 24
9.0%
9.6%
EPS (diluted)
ICLR
ICLR
IVZ
IVZ
Q4 25
$-2.61
Q3 25
$0.03
$0.66
Q2 25
$2.30
$-0.03
Q1 25
$1.90
$0.38
Q4 24
$0.46
Q3 24
$2.36
$0.12
Q2 24
$1.76
$0.29
Q1 24
$2.25
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICLR
ICLR
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$468.9M
$1.0B
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$9.3B
$12.2B
Total Assets
$16.5B
$27.1B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICLR
ICLR
IVZ
IVZ
Q4 25
$1.0B
Q3 25
$468.9M
$973.1M
Q2 25
$390.4M
$922.7M
Q1 25
$526.7M
$821.7M
Q4 24
$986.5M
Q3 24
$695.5M
$1.0B
Q2 24
$506.6M
$878.5M
Q1 24
$396.1M
$895.7M
Total Debt
ICLR
ICLR
IVZ
IVZ
Q4 25
$1.8B
Q3 25
$1.6B
Q2 25
$1.9B
Q1 25
$964.8M
Q4 24
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Q1 24
$1.3B
Stockholders' Equity
ICLR
ICLR
IVZ
IVZ
Q4 25
$12.2B
Q3 25
$9.3B
$14.0B
Q2 25
$9.6B
$13.9B
Q1 25
$9.5B
$14.7B
Q4 24
$14.6B
Q3 24
$9.8B
$14.8B
Q2 24
$9.6B
$14.6B
Q1 24
$9.4B
$14.6B
Total Assets
ICLR
ICLR
IVZ
IVZ
Q4 25
$27.1B
Q3 25
$16.5B
$28.4B
Q2 25
$16.6B
$28.5B
Q1 25
$16.7B
$28.1B
Q4 24
$27.0B
Q3 24
$17.2B
$27.5B
Q2 24
$17.0B
$27.2B
Q1 24
$17.0B
$28.1B
Debt / Equity
ICLR
ICLR
IVZ
IVZ
Q4 25
0.15×
Q3 25
0.12×
Q2 25
0.14×
Q1 25
0.07×
Q4 24
0.06×
Q3 24
0.06×
Q2 24
0.06×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICLR
ICLR
IVZ
IVZ
Operating Cash FlowLast quarter
$387.6M
$455.8M
Free Cash FlowOCF − Capex
$333.9M
$432.2M
FCF MarginFCF / Revenue
16.3%
25.5%
Capex IntensityCapex / Revenue
2.6%
1.4%
Cash ConversionOCF / Net Profit
164.59×
TTM Free Cash FlowTrailing 4 quarters
$1.0B
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICLR
ICLR
IVZ
IVZ
Q4 25
$455.8M
Q3 25
$387.6M
$606.2M
Q2 25
$146.2M
$547.9M
Q1 25
$268.2M
$-84.6M
Q4 24
$316.9M
Q3 24
$402.7M
$438.4M
Q2 24
$218.6M
$489.1M
Q1 24
$327.1M
$-54.4M
Free Cash Flow
ICLR
ICLR
IVZ
IVZ
Q4 25
$432.2M
Q3 25
$333.9M
$586.4M
Q2 25
$113.9M
$530.4M
Q1 25
$239.3M
$-108.0M
Q4 24
$309.9M
Q3 24
$359.3M
$410.0M
Q2 24
$182.3M
$462.4M
Q1 24
$299.9M
$-75.4M
FCF Margin
ICLR
ICLR
IVZ
IVZ
Q4 25
25.5%
Q3 25
16.3%
35.7%
Q2 25
5.6%
35.0%
Q1 25
12.0%
-7.1%
Q4 24
19.5%
Q3 24
17.7%
27.1%
Q2 24
8.6%
31.2%
Q1 24
14.3%
-5.1%
Capex Intensity
ICLR
ICLR
IVZ
IVZ
Q4 25
1.4%
Q3 25
2.6%
1.2%
Q2 25
1.6%
1.2%
Q1 25
1.4%
1.5%
Q4 24
0.4%
Q3 24
2.1%
1.9%
Q2 24
1.7%
1.8%
Q1 24
1.3%
1.4%
Cash Conversion
ICLR
ICLR
IVZ
IVZ
Q4 25
Q3 25
164.59×
1.70×
Q2 25
0.80×
2.78×
Q1 25
1.74×
-0.49×
Q4 24
1.51×
Q3 24
2.04×
7.97×
Q2 24
1.49×
3.70×
Q1 24
1.74×
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ICLR
ICLR

Other Customers$681.3M33%
Clients1125$549.4M27%
Clients15$503.3M25%
Clients610$308.8M15%

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons